88
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Establishment of a novel homogeneous nanoparticle-based assay for sensitive procalcitonin detection of ultra low-volume serum samples

, , , , , , , & show all
Pages 5395-5404 | Published online: 13 Sep 2018

References

  • LiaoTYuanFYuHLiZAn ultrasensitive ELISA method for the detection of procalcitonin based on magnetic beads and enzyme-antibody labeled gold nanoparticlesAnal Methods20168715771585
  • AngusDCLinde-ZwirbleWTLidickerJClermontGCarcilloJPinskyMREpidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of careCrit Care Med20012971303131011445675
  • EngelCBrunkhorstFMBoneHGEpidemiology of sepsis in Germany: results from a national prospective multicenter studyIntens Care Med2007334606618
  • WangHWangHChenSDevelopment of a fluorescent immnunochromatographic assay for the procalcitonin detection of clinical patients in ChinaClin Chim Acta2015444374225659293
  • LiPZhangWZhouXZhangLC60 carboxyfullerene-based functionalised nanohybrids as signal-amplifying tags for the ultrasensitive electrochemical detection of procalcitoninClin Biochem201548315616125280812
  • MeisnerMTschaikowskyKPalmaersTSchmidtJComparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODSCritical Care199931454611056723
  • BalciCSungurtekinHGürsesESungurtekinUKaptanogluBUsefulness of procalcitonin for diagnosis of sepsis in the intensive care unitCrit Care2003718512617745
  • SenerGOzgurERadAYUzunLSayRDenizliARapid real-time detection of procalcitonin using a microcontact imprinted surface plasmon resonance biosensorAnalyst2013138216422642824005005
  • PierrakosCVincentJLSepsis biomarkers: a reviewCrit Care2010141R1520144219
  • CarriganSDScottGTabrizianMToward resolving the challenges of sepsis diagnosisClin Chem20045081301131415166107
  • WolffMBouadmaLWhat procalcitonin brings to management of sepsis in the ICUCrit Care2010146100721138601
  • MorgenthalerNGStruckJFischer-SchulzCBergmannASensitive immunoluminometric assay for the detection of procalcitoninClin Chem200248578879011978614
  • KöszegiTImmunoluminometric detection of human procalcitoninJ Biochem Biophys Methods2002531–315716412406598
  • LiHSunYElseviersJMuyldermansSLiuSWanYA nanobody-based electrochemiluminescent immunosensor for sensitive detection of human procalcitoninAnalyst2014139153718372124931592
  • KrämerPMGouzyMFKessMKleinschmidtUKremmerEDevelopment and characterization of new rat monoclonal antibodies for procalcitoninAnal Bioanal Chem2008392472773618712365
  • QiXHuangYLinZXuLYuHDual-Quantum-Dots-Labeled Lateral Flow Strip Rapidly Quantifies Procalcitonin and C-reactive ProteinNanoscale Res Lett201611116727013227
  • PoulsenFJensenKBA luminescent oxygen channeling immunoassay for the determination of insulin in human plasmaJ Biomol Screen200712224024717259593
  • SzekeresPGLeongKDayTAKingstonAEKarranEHDevelopment of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technologyJ Biomol Screen200813210111118216395
  • PeppardJGlickmanFHeYHuSIDoughtyJGoldbergRDevelopment of a high-throughput screening assay for inhibitors of aggrecan cleavage using luminescent oxygen channeling (AlphaScreen)J Biomol Screen20038214915612844435
  • SoiniEKojolaHTime-resolved fluorometer for lanthanide chelates-a new generation of nonisotopic immunoassaysClin Chem1983291656336682
  • LopezEChypreCAlphaBMathisGEuropium(III) trisbipyridine cryptate label for time-resolved fluorescence detection of polymerase chain reaction products fixed on a solid supportClin Chem19933921962018381731
  • LiuTCHuangHDongZNDevelopment of an amplified luminescent proximity homogeneous assay for quantitative determination of hepatitis B surface antigen in human serumClin Chim Acta201342613914424064424
  • HeALiuTCDongZNA novel immunoassay for the quantization of CYFRA 21-1 in human serumJ Clin Lab Anal201327427728323852784
  • XiongYWuYLuoSDevelopment of a novel immunoassay to detect interactions with the transactivation domain of p53: application to screening of new drugsSci Rep201771918528835687
  • Bielefeld-SevignyMAlphaLISA immunoassay platform- the “no-wash” high-throughput alternative to ELISAAssay Drug Dev Technol200971909219382891